Ogen and Breastfeeding
Studies on Ogen (estropipate) and breastfeeding show that the medication passes through breast milk. These amounts are probably too low to cause significant problems in infants, but since the estrogen hormones in Ogen may decrease the production and quality of breast milk, woman are generally advised to avoid the drug when breastfeeding. Before taking Ogen, breastfeeding women should consult their healthcare providers.
Ogen® (estropipate) is a prescription medication that is most often used to treat menopause symptoms, although it is approved for a few other uses as well. The estrogen hormone in Ogen passes through breast milk and can decrease the quality and quantity of breast milk. Therefore, make sure to check with your healthcare provider before taking Ogen if you are breastfeeding.
Research suggests that Ogen passes through breast milk in low amounts. These amounts are probably too low to cause significant or long-lasting problems in nursing infants.
More importantly, the estrogen hormones in Ogen may decrease the production and quality of breast milk. It is for this reason that estrogen-containing medications, including Ogen and many birth control pills, are usually not recommended for women who are breastfeeding. In fact, estropipate (the hormone in Ogen) is sometimes used to suppress lactation (milk production) and decrease engorgement in women who choose not to breastfeed.
You should talk with your healthcare provider about Ogen and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision about Ogen and breastfeeding that is right for you.